Vicks Nasivin, spray nasal 0.025 % , fl 10 ml
7680546130077
CH-54613
R01AA05
1 / 3
google
Details
- Product number
- 5461303
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
VICKS Nasivin 0.025 %, solution pour pulvérisation nasale
Lösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
11.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 7.50
Specialties list
Yes
Generic
No
SL addition date:
01/10/2006
Authorization holder
Procter & Gamble International
1213 Lancy
Authorization information
- Swissmedic authorization number
- 54613
- Drug name
- VICKS Nasivin, solution pour pulvérisation nasale
- Galenic form
- NASSL
- ATC Code
- R01AA05
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 27/10/1998
- Authorization expiration date
- 31/12/9999
- IT number
- 12.02.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VICKS Nasivin 0.025 % nasal spray 0.25 mg 10 ml
- Description (DE)
- VICKS Nasivin 0.025 % Nasenspray 0.25 mg 10 ml
- Market launch
- 22/07/2004
- Narcotic (BTM)
- No